Logo

American Heart Association

  15
  0


Final ID: MDP1748

An Innovative, Non-invasive, Credit-Card Sized Device for Ambulatory 12 Lead ECG Recording: First-In-Human Experience Compared to Standard 12 Lead ECG

Abstract Body (Do not enter title and authors here): Background: The multiple electrodes needed to generate a 12-lead electrocardiogram (12L ECG) limits its use to traditional health care settings. An innovative credit-card sized unit (HeartBeam, Santa Clara, CA, USA) when placed on the chest without cables captures a vectorcardiogram (VCG). A personalized transformation matrix (PTM) then converts the signals into a 12L ECG.

Objective: This is the first quantitative (standard intervals and amplitudes) and qualitative (rhythm diagnosis) accuracy assessment of a synthesized 12L ECG (Syn 12L) compared to a simultaneously recorded standard 12L ECG (Std 12L) on patients in sinus rhythm (SR) or in a non-life-threatening arrhythmia.

Methods: The 80 patients, who were enrolled at a single center (Dedinje Cardiovascular Research Institute, Belgrade, Serbia), first underwent recording of a Std 12L and VCG to create a unique PTM, which was used to create the Syn 12L from the VCG. Then a simultaneous Std 12L and VCG were recorded. The quantitative endpoint was the calculated difference (mean and standard deviation [SD]) between the Syn 12L and Std 12L in a series of intervals (RR, PQ, QJ, and QT) and amplitudes (P wave, R wave, and T wave). For the qualitative endpoint, 2 blinded electrophysiology physicians (EP) classified the Syn 12L and Std 12L arrhythmia status.

Results: Of the 80 patients, 41 were in SR and 39 in another rhythm (3:SR with PACs, 5:SR with PVCs, 1:SR with pre-excitation, 16:atrial fibrillation, 3:atrial flutter, 2:atrial pacing, and 9:ventricular pacing). The interval and amplitude differences are listed in the table. Rhythm classification by the blinded EPs demonstrated a sensitivity of 94.9% (95% CI: 82.7-99.4%) and specificity of 100% (95% CI: 91.4-100%) compared to Std 12L.

Conclusion: In this first study comparing the performance of a 12L ECG created from a credit card sized VCG recorder, the 12L Syn demonstrated clinically equivalent interval and amplitude accuracy and excellent agreement in arrhythmia classification when compared to a simultaneously recorded 12L Std. This approach holds significant promise, potentially permitting patients to obtain a 12L ECG outside of a health care setting with a compact, easy to use device.
  • Deering, Thomas  ( Piedmont Heart Institute , Atlanta , Georgia , United States )
  • Vukajlovic, Dejan  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Babic, Milos  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Djurdjevic, Branko  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Atanasoski, Vladimir  ( HeartBeam Inc. , Santa Clara , California , United States )
  • Miletic, Marjan  ( HeartBeam Inc. , Santa Clara , California , United States )
  • Mittal, Suneet  ( Valley Health System , Paramus , New Jersey , United States )
  • Sanders, Prashanthan  ( University of Adelaide , Adelaide , South Australia , Australia )
  • Author Disclosures:
    Thomas Deering: DO have relevant financial relationships ; Speaker:Sanofi:Past (completed) ; Speaker:Pfizer:Past (completed) ; Speaker:AltaThera:Past (completed) ; Consultant:HeartBeam:Active (exists now) ; Consultant:Preventice:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott: Clinical Study Review Committee:Past (completed) ; Consultant:PaceMate:Active (exists now) ; Consultant:CVRx:Past (completed) ; Researcher:Milestone:Past (completed) | Dejan Vukajlovic: No Answer | Milos Babic: No Answer | Branko Djurdjevic: DO NOT have relevant financial relationships | Vladimir Atanasoski: DO have relevant financial relationships ; Consultant:HeartBeam inc:Active (exists now) ; Individual Stocks/Stock Options:HeartBeam inc:Active (exists now) | Marjan Miletic: DO NOT have relevant financial relationships | Suneet Mittal: No Answer | Prashanthan Sanders: DO have relevant financial relationships ; Advisor:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Abbott :Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Advisor:Pacemate:Active (exists now) ; Advisor:CathRx:Active (exists now) ; Advisor:Abbott :Active (exists now) ; Advisor:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pushing the Boundaries: Innovations in Electrophysiology

Monday, 11/18/2024 , 11:10AM - 12:25PM

Moderated Digital Poster Session

More abstracts on this topic:
All-cause and Cause-specific Mortality Disparities in the District of Columbia: Temporal Trends from 2000 to 2020

Hashemian Maryam, Conners Katherine, Powell-wiley Tiffany, Rafi Rebeka, Henriquez Santos Gretell, Shearer Joe, Joo Jungnam, Shiels Meredith, Roger Veronique

Advocacy in Cardiology: Healthcare lobbying and campaign finance activities of major cardiovascular professional societies, 2003 to 2023

Patel Prem, Milks Michael, Miller Andrew, Mehta Laxmi

More abstracts from these authors:
Artificial Intelligence-based improvement of smartwatch detection of AF

Wan Elaine, Glotzer Taya, Mittal Suneet, Senepart Oceane, Lefebvre Baptiste

A Personal Risk Assessment Device in Patients with Chest Pain

Shvilkin Alexei, Zlatic Natasa, Atanasoski Vladimir, Grujovic Zdolsek Sanja, Popovic Maneski Lana, Miletic Marjan, Vukcevic Vladan

You have to be authorized to contact abstract author. Please, Login
Not Available